Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1975 Jun;122(6):526–530.

Clindamycin--efficacy and toxicity.

R I Frankel
PMCID: PMC1129812  PMID: 1094736

Full text

PDF
526

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelrod J., Meyers B. R., Hirschman S. Z. 7-Chlorolincomycin therapy of pulmonary infections due to Myoplasma pneumoniae. Antimicrob Agents Chemother. 1972 Dec;2(6):499–501. doi: 10.1128/aac.2.6.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barry A. L., Garcia F., Thrupp L. D. An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogens. Am J Clin Pathol. 1970 Feb;53(2):149–158. doi: 10.1093/ajcp/53.2.149. [DOI] [PubMed] [Google Scholar]
  3. Bartlett J. G., Sutter V. L., Finegold S. M. Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med. 1972 Nov 16;287(20):1006–1010. doi: 10.1056/NEJM197211162872002. [DOI] [PubMed] [Google Scholar]
  4. Benner E. J., Tellman W. H. Pseudomembraneous colitis as a sequel to oral lincomycin therapy. Am J Gastroenterol. 1970 Jul;54(1):55–58. [PubMed] [Google Scholar]
  5. Bodner S. J., Koenig M. G., Treanor L. L., Goodman J. S. Antibiotic susceptibility testing of Bacteroides. Antimicrob Agents Chemother. 1972 Aug;2(2):57–60. doi: 10.1128/aac.2.2.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bongiorno J. R., Alcasid M. L., Chiaramonte L. T. Treatment of pneumonia in children with Cleocin palmitate. Curr Ther Res Clin Exp. 1971 Nov;13(11):667–670. [PubMed] [Google Scholar]
  7. Chow A. W., Guze L. B. Bacteroidaceae bacteremia: clinical experience with 112 patients. Medicine (Baltimore) 1974 Mar;53(2):93–126. [PubMed] [Google Scholar]
  8. Cohen L. E., McNeill C. J., Wells R. F. Clindamycin-associated colitis. JAMA. 1973 Mar 19;223(12):1379–1380. [PubMed] [Google Scholar]
  9. De Haan R. M., Schellenberg D., Vanden Bosch W. D., Maile M. H. Clindamycin palmitate in healthy men: general tolerance and effect on stools. Curr Ther Res Clin Exp. 1972 Feb;14(2):81–90. [PubMed] [Google Scholar]
  10. DeFord J. W., Daly J. J., Cooper A. D., Molinaro J. R. Letter: Gastrointestinal manifestations of adverse drug reactions: clindamycin. Am J Dig Dis. 1974 Jun;19(6):581–581. doi: 10.1007/BF01072747. [DOI] [PubMed] [Google Scholar]
  11. Douglas R. L., Kislak J. W. Treatment of Bacteroides fragilis bacteremia with clindamycin. J Infect Dis. 1973 Oct;128(4):569–571. doi: 10.1093/infdis/128.4.569. [DOI] [PubMed] [Google Scholar]
  12. Ecker J. A., Williams R. G., McKittrick J. E., Failing R. M. Pseudomembraneous enterocolitis--an unwelcome gastrointestinal complication of antibiotic therapy. Am J Gastroenterol. 1970 Sep;54(3):214–228. [PubMed] [Google Scholar]
  13. Fass R. J., Saslaw S. Clindamycin: clinical and laboratory evaluation of parenteral therapy. Am J Med Sci. 1972 May;263(5):368–382. [PubMed] [Google Scholar]
  14. Fass R. J., Scholand J. F., Hodges G. R., Saslaw S. Clindamycin in the treatment of serious anaerobic infections. Ann Intern Med. 1973 Jun;78(6):853–859. doi: 10.7326/0003-4819-78-6-853. [DOI] [PubMed] [Google Scholar]
  15. Feigin R. D., Shackelford P., Keeney R. E., Middelkamp J. N. Treatment of penicillin-resistant staphylococcal infections with clindamycin. Am J Med Sci. 1971 Apr;261(4):207–212. doi: 10.1097/00000441-197104000-00004. [DOI] [PubMed] [Google Scholar]
  16. Fekety F. R., Jr Gastrointestinal complications of antibiotic therapy. JAMA. 1968 Jan 15;203(3):210–212. [PubMed] [Google Scholar]
  17. Felner J. M., Dowell V. R., Jr "Bacteroides" bacteremia. Am J Med. 1971 Jun;50(6):787–796. doi: 10.1016/0002-9343(71)90187-2. [DOI] [PubMed] [Google Scholar]
  18. Finegold S. M., Rosenblatt J. E. Practical aspects of anaerobic sepsis. Medicine (Baltimore) 1973 Jul;52(4):311–322. doi: 10.1097/00005792-197307000-00010. [DOI] [PubMed] [Google Scholar]
  19. Frederick J., Braude A. I. Anaerobic infection of the paranasal sinuses. N Engl J Med. 1974 Jan 17;290(3):135–137. doi: 10.1056/NEJM197401172900304. [DOI] [PubMed] [Google Scholar]
  20. Geddes A. M., Bridgwater F. A., Williams D. N., Oon J., Grimshaw G. J. Clinical and bacteriological studies with clindamycin. Br Med J. 1970 Jun 20;2(5711):703–704. doi: 10.1136/bmj.2.5711.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gorbach S. L., Menda K. B., Thadepalli H., Keith L. Anaerobic microflora of the cervix in healthy women. Am J Obstet Gynecol. 1973 Dec 15;117(8):1053–1055. doi: 10.1016/0002-9378(73)90753-9. [DOI] [PubMed] [Google Scholar]
  22. Kaplan K., Weinstein L. Lincomycin. Pediatr Clin North Am. 1968 Feb;15(1):131–139. doi: 10.1016/s0031-3955(16)32094-6. [DOI] [PubMed] [Google Scholar]
  23. Kerstein M. D. Intravenous clindamycin phosphate in staphylococcal infections. Curr Ther Res Clin Exp. 1972 Mar;14(3):107–112. [PubMed] [Google Scholar]
  24. Kislak J. W. The susceptibility of Bacteroides fragilis to 24 antibiotics. J Infect Dis. 1972 Mar;125(3):295–299. doi: 10.1093/infdis/125.3.295. [DOI] [PubMed] [Google Scholar]
  25. Levison M. E., Bran J. L., Ries K. Treatment of anaerobic bacterial infections with clindamycin-2-phosphate. Antimicrob Agents Chemother. 1974 Mar;5(3):276–280. doi: 10.1128/aac.5.3.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Manashil G. B., Kern J. A. Nonspecific colitis following oral lincomycin therapy. Am J Gastroenterol. 1973 Oct;60(4):394–399. [PubMed] [Google Scholar]
  27. Martin W. J., Gardner M., Washington J. A., 2nd In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother. 1972 Feb;1(2):148–158. doi: 10.1128/aac.1.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. McGehee R. F., Jr, Smith C. B., Wilcox C., Finland M. Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. Am J Med Sci. 1968 Nov;256(5):279–292. doi: 10.1097/00000441-196811000-00002. [DOI] [PubMed] [Google Scholar]
  29. Mildvan D., Ravreby W., Meyers B. R., Hirschman S. Z. Parenteral clindamycin therapy of severe infections. Mt Sinai J Med. 1973 Nov-Dec;40(6):744–751. [PubMed] [Google Scholar]
  30. Moore W. E., Cato E. P., Holdeman L. V. Anaerobic bacteria of the gastrointestinal flora and their occurrence in clinical infections. J Infect Dis. 1969 Jun;119(6):641–649. doi: 10.1093/infdis/119.6.641. [DOI] [PubMed] [Google Scholar]
  31. Moore W. E., Holdeman L. V. Identification of anaerobic bacteria. Am J Clin Nutr. 1972 Dec;25(12):1306–1313. doi: 10.1093/ajcn/25.12.1306. [DOI] [PubMed] [Google Scholar]
  32. Nobles E. R., Jr Bacteroides infections. Ann Surg. 1973 May;177(5):601–606. [PMC free article] [PubMed] [Google Scholar]
  33. Oppenheimer S., Turek M. Laboratory and clinical evaluation of 7-chloro-7-deoxylincomycin. Am J Med Sci. 1968 Nov;256(5):314–321. doi: 10.1097/00000441-196811000-00006. [DOI] [PubMed] [Google Scholar]
  34. Pittman F. E., Pittman J. C., Humphrey C. D. Letter: Lincomycin and pseudomembranous colitis. Lancet. 1974 Mar 16;1(7855):451–452. doi: 10.1016/s0140-6736(74)92402-7. [DOI] [PubMed] [Google Scholar]
  35. Pugliese W. M., Mesches D. N., Wiersum J., Henriquez C. L., 3rd, Krivda J. F. Double-blind study: Cleocin Palmitate and Erythrocin Pediatric in otitis media in children. Curr Ther Res Clin Exp. 1972 Jan;14(1):31–34. [PubMed] [Google Scholar]
  36. Quintiliani R., McGreevy M. J. Clindamycin (Cleocin) in bacterial pneumonia. Curr Ther Res Clin Exp. 1970 Nov;12(11):701–705. [PubMed] [Google Scholar]
  37. Sanders E. Lincomycin versus erythromycin: a choice or an echo. Ann Intern Med. 1969 Mar;70(3):585–590. doi: 10.7326/0003-4819-70-3-585. [DOI] [PubMed] [Google Scholar]
  38. Shimkin P. M., Link R. J. Pseudomembranous colitis: a consideration in the barium enema differential diagnosis of acute generalized ulcerative colitis. Br J Radiol. 1973 Jun;46(546):437–439. doi: 10.1259/0007-1285-46-546-437. [DOI] [PubMed] [Google Scholar]
  39. Simmons H. E., Stolley P. D. This is medical progress? Trends and consequences of antibiotic use in the United States. JAMA. 1974 Mar 4;227(9):1023–1028. doi: 10.1001/jama.227.9.1023. [DOI] [PubMed] [Google Scholar]
  40. Smilack J. D., Burgin W. W., Jr, Moore W. L., Jr, Sanford J. P. Mycoplasma pneumoniae pneumonia and clindamycin therapy. Failure to demonstrate efficacy. JAMA. 1974 May 6;228(6):729–731. [PubMed] [Google Scholar]
  41. Stanley R. J., Melson G. L., Tedesco F. J. The spectrum of radiographic findings in antibiotic-related pseudomembranous colitis. Radiology. 1974 Jun;111(3):519–524. doi: 10.1148/111.3.519. [DOI] [PubMed] [Google Scholar]
  42. Stillerman M., Isenberg H. D., Facklam R. R. Streptococcal pharyngitis therapy: comparison of clindamycin palmitate and potassium phenoxymethyl penicillin. Antimicrob Agents Chemother. 1973 Nov;4(5):514–520. doi: 10.1128/aac.4.5.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Stroehlein J. R., Sedlack R. E., Hoffman H. N., 2nd, Newcomer A. D. Clindamycin-associated colitis. Mayo Clin Proc. 1974 Apr;49(4):240–243. [PubMed] [Google Scholar]
  44. Sutter V. L., Finegold S. M. Antibiotic disc susceptibility tests for rapid presumptive identification of Gram-negative anaerobic bacilli. Appl Microbiol. 1971 Jan;21(1):13–20. doi: 10.1128/am.21.1.13-20.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sutter V. L., Kwok Y. Y., Finegold S. M. Standardized antimicrobial disc susceptibility testing of anaerobic bacteria. I. Susceptibility of Bacteroides fragilis to tetracycline. Appl Microbiol. 1972 Feb;23(2):268–275. doi: 10.1128/am.23.2.268-275.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sutter V. L., Kwok Y., Finegold S. M. Susceptibility of Bacteroides fragilis to six antibiotics determined by standardized antimicrobial disc susceptibility testing. Antimicrob Agents Chemother. 1973 Feb;3(2):188–193. doi: 10.1128/aac.3.2.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Tedesco F. J., Stanley R. J., Alpers D. H. Diagnostic features of clindamycin-associated pseudomembranous colitis. N Engl J Med. 1974 Apr 11;290(15):841–843. doi: 10.1056/NEJM197404112901508. [DOI] [PubMed] [Google Scholar]
  48. Tully T. E., Feinberg S. B. A reappearance of antibiotic-induced pseudomembranous enterocolitis. Radiology. 1974 Mar;110(3):563–567. doi: 10.1148/110.3.563. [DOI] [PubMed] [Google Scholar]
  49. Viteri A. L., Howard P. H., Dyck W. P. The spectrum of lincomycin-clindamycin colitis. Gastroenterology. 1974 Jun;66(6):1137–1144. [PubMed] [Google Scholar]
  50. Wells R. F., Cohen L. E., McNeill C. J. Letter: Clindamycin and pseudomembranous colitis. Lancet. 1974 Jan 12;1(7846):66–66. doi: 10.1016/s0140-6736(74)93067-0. [DOI] [PubMed] [Google Scholar]
  51. Wilkins T. D., Thiel T. Resistance of some species of Clostridium to clindamycin. Antimicrob Agents Chemother. 1973 Jan;3(1):136–137. doi: 10.1128/aac.3.1.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Wilkinson S. P. Letter: Clindamycin and colitis. Lancet. 1974 Mar 9;1(7854):415–415. doi: 10.1016/s0140-6736(74)93185-7. [DOI] [PubMed] [Google Scholar]
  53. Wise R., Tudway A. J., Pelta D. E. Letter: Clindamycin and pseudomembranous colitis. Lancet. 1974 May 4;1(7862):878–879. doi: 10.1016/s0140-6736(74)90543-1. [DOI] [PubMed] [Google Scholar]
  54. Ziment I. Complications of antibiotic therapy. Calif Med. 1972 Nov;117(5):24–48. [PMC free article] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES